Lung cancer surgery risks under the microscope: 1,000 patients studied
NCT ID NCT07401498
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks 1,000 people with advanced non-small cell lung cancer who are having surgery to remove lymph nodes. The goal is to see how often complications like nerve damage or bleeding happen and what factors make them more likely. By understanding these risks, doctors hope to make surgery safer in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help surgeons predict and reduce complications from lymph node removal in lung cancer surgery.
- What could go wrong
- This is an observational study, not testing a new treatment. It may not lead to immediate changes in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Regional Clinical Oncology Dispensary
Ulyanovsk, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart cancer therapy: tailoring lung cancer treatment with a simple blood test
- New drug cocktail targets tough lung cancer
- Blood test could speed up lung cancer treatment decisions
- New drug duo takes on advanced lung cancer
- Could a common antioxidant boost chemo for advanced lung cancer?
- New study aims to ease pain after breast cancer surgery